Press Releases
Washington, D.C. (Jan. 31, 2023)—Today, Rep. Jamie Raskin, Ranking Member of the Committee on Oversight and Accountability, sent a letter to Kimberly A. Cheatle, Director of the United States Secret Service, requesting information on who had access to former President Trump's Mar-a-Lago Club and former Vice President Mike Pence's residence since leaving office.
Washington, D.C. (Jan. 26, 2023)—Today, Rep. Jamie Raskin, Ranking Member of the Committee on Oversight and Accountability, issued the following statement after Democratic Leader Hakeem Jeffries announced the members of the Committee for the 118th Congress:
Washington, D.C. (Jan. 24, 2023)—Today, Rep. Jamie Raskin, Ranking Member of the Committee on Oversight and Accountability, issued the following statement after classified documents were found in former Vice President Mike Pence's private residence:
Washington, D.C. (Jan. 12, 2023)—Today, Rep. Jamie Raskin, Ranking Member of the Committee on Oversight and Accountability, issued the following statement after Attorney General Merrick Garland announced a special counsel to review documents turned over by President Biden:
Washington, D.C. (Jan. 11, 2023)—Today, Rep. Jamie Raskin, Ranking Member of the Committee on Oversight and Accountability, issued the following statement on House Republicans passing H.R. 26, which politicizes reproductive health care and criminalizes doctors and nurses who provide abortion services, and H. Con. Res. 3, which ignores the spike in violence and threats to abortion providers and patients:
Washington, D.C. (Jan. 11, 2023)—Today, Rep. Jamie Raskin, Ranking Member of the Committee on Oversight and Accountability, issued the following statement after Oversight Committee Chair James Comer announced plans to hold a hearing with former Twitter executives next month:
Washington D.C. (Dec. 29, 2022)—Today, Oversight and Reform Committee Chairwoman Carolyn B. Maloney (D-NY) and Energy and Commerce Committee Chairman Frank Pallone, Jr. (D-NJ) released a staff report following an 18-month investigation into the Food and Drug Administration's (FDA) regulatory review and approval process of Biogen's Alzheimer's disease drug Aduhelm, and Biogen's pricing of Aduhelm.
Washington, D.C. (Dec. 23, 2022)—Today, Rep. Carolyn B. Maloney, Chairwoman of the Committee on Oversight and Reform, released the following statement regarding the Committee's activity for the 117th Congress:
Washington, D.C. (Dec. 22, 2022)—Today, Rep. Carolyn B. Maloney, Chairwoman of the Committee on Oversight and Reform, Rep. Jamie Raskin, Chairman of the Subcommittee on Civil Rights and Civil Liberties, and Rep.
Washington, D.C. (Dec. 22, 2022)—Today, Rep. Carolyn B. Maloney, Chairwoman of the Committee on Oversight and Reform, released the following statement after Rep. Jamie Raskin (D-MD) was elected Ranking Member of the Committee on Oversight and Reform for the 118th Congress: